Mosaic ImmunoEngineering, Inc.
CPMV
$0.897
$0.39980.12%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.48% | 18.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.82% | 16.38% | |||
| Operating Income | 14.82% | -16.38% | |||
| Income Before Tax | 6.45% | -20.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.13% | -18.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.13% | -18.50% | |||
| EBIT | 14.82% | -16.38% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 5.18% | -18.96% | |||
| Normalized Basic EPS | 6.37% | -20.77% | |||
| EPS Diluted | 5.18% | -18.96% | |||
| Normalized Diluted EPS | 6.37% | -20.77% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||